Diffusion-Weighted MRI: Distinction of Skull Base Chordoma from Chondrosarcoma

References

1. 1.↵
   Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain Tumors in the United States, 1997–2001. Hinsdale, Illinois: Central Brain Tumor Registry of the United States
2. 2.↵
   1. Heffelfinger MJ,
   2. Dahlin DC,
   3. MacCarty CS,
   4. et al

   . Chordomas and cartilaginous tumors of the skull base. Cancer 1973;32:410–20

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Almefty K,
   2. Pravdenkova S,
   3. Colli BO,
   4. et al

   . Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer 2007;110:2456–67
4. 4.↵
   1. Cho YH,
   2. Kim JH,
   3. Khang SK,
   4. et al

   . Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients. Neurosurg Rev 2008;31:35–43

   PubMed
5. 5.↵
   1. Burrow JF,
   2. Stewart MJ

   . Original papers: malignant spheno-occipital chordoma. J Neurol Psychopathol 1923;15:205–17
6. 6.↵
   1. Pamir MN,
   2. Ozduman K

   . Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas. Eur J Radiol 2006;58:461–70

   CrossRefPubMed
7. 7.↵
   1. Fletcher CDM,
   2. Unni KK,
   3. Mertens F

   1. Mirra JM,
   2. Nelson SD,
   3. Della Rocca C,
   4. et al

   . Chordoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:315–17
8. 8.↵
   1. Hoch BL,
   2. Nielsen GP,
   3. Liebsch NJ,
   4. et al

   . Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol 2006;30:811–18

   CrossRefPubMed
9. 9.↵
   1. Coffin CM,
   2. Swanson PE,
   3. Wick MR,
   4. et al

   . Chordoma in childhood and adolescence: a clinicopathologic analysis of 12 cases. Arch Pathol Lab Med 1993;117:927–33

   PubMed
10. 10.↵
    1. Mobley BC,
    2. McKenney JK,
    3. Bangs CD,
    4. et al

    . Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol 2010;120:745–53

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Fletcher CDM,
    2. Unni KK,
    3. Mertens F

    1. Bertoni F,
    2. Bacchini P,
    3. Hogendoorn PC

    . Chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:247–51
12. 12.↵
    1. Oot RF,
    2. Melville GE,
    3. New PF,
    4. et al

    . The role of MR and CT in evaluating clival chordomas and chondrosarcomas. AJR Am J Roentgenol 1988;151:567–75

    PubMed
13. 13.↵
    1. Bourgouin PM,
    2. Tampieri D,
    3. Robitaille Y,
    4. et al

    . Low-grade myxoid chondrosarcoma of the base of the skull: CT, MR, and histopathology. J Comput Assist Tomogr 1992;16:268–73

    PubMedWeb of Science
14. 14.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Kochi M,
    4. et al

    . Usefulness of diffusion-weighted MRI with echo-planar technique in evaluation of cellularity in gliomas. J Mag Res Imaging 1999;9:53–60

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Guo AC,
    2. Cummings TJ,
    3. Dash RC,
    4. et al

    . Lymphomas and high-grade astrocytomas: Comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Rumboldt Z,
    2. Camacho DL,
    3. Lake D,
    4. et al

    . Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006;27:1362–69

    Abstract/FREE Full Text
17. 17.↵
    1. Le Bihan D,
    2. Breton E,
    3. Lallemand D,
    4. et al

    . MR imaging of intravoxel incoherent motions: Application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Filippi CG,
    2. Edgar MA,
    3. Ulug AM,
    4. et al

    . Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001;22:65–72

    Abstract/FREE Full Text
19. 19.↵
    1. Lichtenstein L,
    2. Jaffe HL

    . Chondrosarcoma of bone. Am J Pathol 1943;19:553–89

    PubMed
20. 20.↵
    1. Dahlin DC,
    2. MacCarty CS

    . Chordoma. Cancer 1952;5:1170–78

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Evans HL,
    2. Ayala AG,
    3. Romsdahl MM

    . Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer 1977;40:818–31

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Hayashida Y,
    2. Hirai T,
    3. Yakushiji T,
    4. et al

    . Evaluation of diffusion-weighted imaging for the differential diagnosis of poorly contrast-enhanced and T2-prolonged bone masses: initial experience. J Magn Reson Imaging 2006;23:377–82

    CrossRefPubMed
23. 23.↵
    1. Ginat DT,
    2. Mangla R,
    3. Yeaney G,
    4. et al

    . Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. AJR Am J Roentgenol 2012:198:W597–601

    CrossRefPubMed